brufen forte 40 mg/ml oral suspension
abbott arzneimittel gmbh - 40 mg/ml oral suspension
ospexin 250 mg/5 ml granules for oral suspension
sandoz gmbh - Цефалексина - 250 mg/5 ml granules for oral suspension
biodroxil 250 mg/5ml powder for oral suspension
sandoz gmbh - Цефадроксил - 250 mg/5ml powder for oral suspension
decapeptyl depot 3,75 mg powder and solvent for suspension for injection
ferring gmbh - Трипторелин - 3,75 mg powder and solvent for suspension for injection
ospamox 250 mg/5 ml powder for oral suspension
sandoz gmbh - Амоксицилин - 250 mg/5 ml powder for oral suspension
ospamox 500 mg /5 ml powder for oral suspension
sandoz gmbh - Амоксицилин - 500 mg /5 ml powder for oral suspension
amoksiklav 400 mg/ 57 mg/5 ml powder for oral suspension
lek pharmaceuticals d.d.. - Амоксицилин и инхибитор на ензима - 400 mg/ 57 mg/5 ml powder for oral suspension
biobos respi 5 plus lyophilisate and suspension for suspension for injection
„Лекоом“ АД - lyophilisate - live attenuated bovine herpesvirus type 1 (bhv-1), strain bio 27 : ibr ge-negative; suspension – bovine respiratory syncytial virus (brsv) inactivated, strain bio 24; bovine parainfluenza 3 virus (pi3v) inactivated, strain bio 23; bovine viral diarrhoea virus (bvdb) inactivated, strain bio 25; manheimia (pasteurella) hemolytica, inactivated, strain dsm 5283, serotype А1 - инжекционна суспензия - 105.7-107.5 tcid50/ 2ml; rp ≥ 1/ 2ml - говеда
pentaxim powder and suspension for suspension for injection
sanofi pasteur s.a. - Дифтерия, тетанус, коклюш (бесклеточный компонент) и полиомиелит (инактивированная) и haemophilus тип b, конюгирана ваксина (адсорбированная) - powder and suspension for suspension for injection
cabometyx
ipsen pharma - cabozantinib (s)-malate - carcinoma, renal cell; carcinomas, hepatocellular - Антинеопластични средства - renal cell carcinoma (rcc)cabometyx is indicated as monotherapy for the treatment of advanced renal cell carcinoma (rcc):in treatment-naïve adults with intermediate or poor risk,in adults following prior vascular endothelial growth factor (vegf)-targeted therapy. cabometyx, in combination with nivolumab, is indicated for the first-line treatment of advanced renal cell carcinoma in adults. hepatocellular carcinoma (hcc)cabometyx is indicated as monotherapy for the treatment of hepatocellular carcinoma (hcc) in adults who have previously been treated with sorafenib.